Literature DB >> 21325409

The Epstein-Barr virus BRRF1 protein, Na, induces lytic infection in a TRAF2- and p53-dependent manner.

Stacy R Hagemeier1, Elizabeth A Barlow, Ariel A Kleman, Shannon C Kenney.   

Abstract

The Epstein-Barr virus (EBV) BRRF1 lytic gene product (Na) is encoded within the same immediate-early region as the BZLF1 (Z) and BRLF1(R) gene products, but its role during EBV infection has not been well defined. We previously showed that Na cooperates with the R protein to induce lytic gene expression in latently infected EBV-positive 293 cells, and in some EBV-negative cell lines it can activate the Z promoter in reporter gene assays. Here we show that overexpression of Na alone is sufficient to induce lytic gene expression in several different latently infected epithelial cell lines (Hone-Akata, CNE2-Akata, and AGS-Akata), while knockdown of endogenous Na expression reduces lytic gene expression. Consistent with its ability to interact with tumor necrosis factor receptor-associated factor 2 (TRAF2) in a yeast two-hybrid assay, we demonstrate that Na interacts with TRAF2 in cells. Furthermore, we show that TRAF2 is required for Na induction of lytic gene expression, that Na induces Jun N-terminal protein kinase (JNK) activation in a TRAF2-dependent manner, and that a JNK inhibitor abolishes the ability of Na to disrupt viral latency. Additionally, we show that Na and the tumor suppressor protein p53 cooperate to induce lytic gene expression in epithelial cells (including the C666-1 nasopharyngeal carcinoma cell line), although Na does not appear to affect p53 function. Together these data suggest that Na plays an important role in regulating the switch between latent and lytic infection in epithelial cells and that this effect requires both the TRAF2 and p53 cellular proteins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325409      PMCID: PMC3126225          DOI: 10.1128/JVI.01856-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells.

Authors:  Angela Kwok Fung Lo; Kwok Wai Lo; Sai Wah Tsao; Hing Lok Wong; Jan Wai Ying Hui; Ka Fai To; Diane S Hayward; Yiu Loon Chui; Yu Lung Lau; Kenzo Takada; Dolly P Huang
Journal:  Neoplasia       Date:  2006-03       Impact factor: 5.715

Review 2.  Physiological roles and mechanisms of signaling by TRAF2 and TRAF5.

Authors:  Ping-Yee Billie Au; Wen-Chen Yeh
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

3.  Critical role of p53 in histone deacetylase inhibitor-induced Epstein-Barr virus Zta expression.

Authors:  Shih-Shin Chang; You-Chang Lo; Huey-Huey Chua; Hsin-Yi Chiu; Shu-Chun Tsai; Jen-Yang Chen; Kwok-Wai Lo; Ching-Hwa Tsai
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

4.  JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

Authors:  B Dérijard; M Hibi; I H Wu; T Barrett; B Su; T Deng; M Karin; R J Davis
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

5.  The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms.

Authors:  Amy Mauser; Shin'ichi Saito; Ettore Appella; Carl W Anderson; William T Seaman; Shannon Kenney
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival.

Authors:  S Y Lee; A Reichlin; A Santana; K A Sokol; M C Nussenzweig; Y Choi
Journal:  Immunity       Date:  1997-11       Impact factor: 31.745

7.  Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.

Authors:  O Devergne; E Hatzivassiliou; K M Izumi; K M Kaye; M F Kleijnen; E Kieff; G Mosialos
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

8.  Sequestration of TRAF2 into stress granules interrupts tumor necrosis factor signaling under stress conditions.

Authors:  Woo Jae Kim; Sung Hoon Back; Vit Kim; Incheol Ryu; Sung Key Jang
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 9.  Tumor necrosis factor receptor-associated factors (TRAFs).

Authors:  J R Bradley; J S Pober
Journal:  Oncogene       Date:  2001-10-01       Impact factor: 9.867

10.  Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism.

Authors:  S Zalani; E Holley-Guthrie; S Kenney
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

View more
  21 in total

1.  Amplification of JNK signaling is necessary to complete the murine gammaherpesvirus 68 lytic replication cycle.

Authors:  James A Stahl; Clinton R Paden; Shweta S Chavan; Veronica MacLeod; Ricky D Edmondson; Samuel H Speck; J Craig Forrest
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

Review 2.  Regulation of the latent-lytic switch in Epstein-Barr virus.

Authors:  Shannon C Kenney; Janet E Mertz
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

3.  Investigating genetic-and-epigenetic networks, and the cellular mechanisms occurring in Epstein-Barr virus-infected human B lymphocytes via big data mining and genome-wide two-sided NGS data identification.

Authors:  Cheng-Wei Li; Bo-Ren Jheng; Bor-Sen Chen
Journal:  PLoS One       Date:  2018-08-22       Impact factor: 3.240

4.  Retrograde Regulation by the Viral Protein Kinase Epigenetically Sustains the Epstein-Barr Virus Latency-to-Lytic Switch To Augment Virus Production.

Authors:  Xiaofan Li; Sergei V Kozlov; Ayman El-Guindy; Sumita Bhaduri-McIntosh
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

5.  The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli.

Authors:  Stacy R Hagemeier; Elizabeth A Barlow; Qiao Meng; Shannon C Kenney
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

Review 6.  Oncogenic viruses and tumor glucose metabolism: like kids in a candy store.

Authors:  Evan Noch; Kamel Khalili
Journal:  Mol Cancer Ther       Date:  2012-01       Impact factor: 6.261

7.  Structure of the Open Reading Frame 49 Protein Encoded by Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Kelly Hew; Saranya Veerappan; Daniel Sim; Tobias Cornvik; Pär Nordlund; Sue-Li Dahlroth
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

8.  Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells.

Authors:  Tawin Iempridee; Jessica A Reusch; Andrew Riching; Eric C Johannsen; Sinisa Dovat; Shannon C Kenney; Janet E Mertz
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

9.  Activation and repression of Epstein-Barr Virus and Kaposi's sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acids.

Authors:  Kelly L Gorres; Derek Daigle; Sudharshan Mohanram; George Miller
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

10.  Cohesins repress Kaposi's sarcoma-associated herpesvirus immediate early gene transcription during latency.

Authors:  Horng-Shen Chen; Priyankara Wikramasinghe; Louise Showe; Paul M Lieberman
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.